Bildyos
Product Images NDC 78206-193

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Bildyos (NDC 78206-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pic1 Henlius Step For Ifu)

Instructional diagram illustrating the components and states of the BILDYOS prefilled syringe. The 'Before use' section labels the needle safety device, black needle cap, needle safety spring, syringe barrel, finger grips, and plunger. The 'After use' section shows the used needle safety spring, used needle, used syringe barrel, used plunger, and the black needle cap removed.*

FDA Label Image

Figure 2 (Pic2 Henlius Step For Ifu)

An instructional illustration showing a hand pulling the plunger of a syringe upward, with the other hand holding the syringe barrel steady. A red arrow indicates the upward direction of the plunger movement.*

FDA Label Image

Figure 3 (Pic3 Henlius Step For Ifu)

An anatomical illustration showing the front view of a human body with highlighted areas on the upper arms, abdomen, and front thighs. The diagram likely indicates application or injection sites for a medication such as BILDYOS.*

FDA Label Image

Figure 4 (Pic4 Henlius Step For Ifu)

An instructional illustration depicting the use of a syringe. A hand holds the syringe with the needle pointing downward and is positioned above a site on a person's abdomen, indicating an injection procedure.*

FDA Label Image

Figure 5 (Pic5 Henlius Step For Ifu)

Illustration showing a hand operating a syringe-like device with a red arrow indicating upward motion for injection or activation. The image depicts the procedure for using the device but does not include text or further context.*

FDA Label Image

Figure 6 (Pic6 Henlius Fig1 Cumulative Incidence Of Hip Fractures Over 3 Years)

A line graph showing patient hip fracture incidence (%) over 36 study months for two groups: placebo and Denosumab. The x-axis represents study months, ranging from 0 to 36, and the y-axis represents patient hip fracture incidence percentage from 0 to 10%. The placebo group is depicted with a dashed line, and the Denosumab group with a solid line, illustrating lower hip fracture incidence in the Denosumab group throughout the study period.*

FDA Label Image

Figure 7 (Pic7 Henlius Organon Logo)

Box packaging of BILDYOS 10 mg film-coated tablets by Organon LLC. The front panel of the carton shows the brand name BILDYOS prominently, with a dosage strength of 10 mg. The package includes 30 film-coated tablets. The design features a white background with orange and red accents.*

FDA Label Image

Figure 8 (Pic8 Henlius Organon Logo)

BILDYOS 4 mg tablets packaging label by Organon LLC. The label shows the product name BILDYOS with the strength of 4 mg. It includes standard labeling information such as directions to see the prescribing information, manufacturer details, and lot number placeholders. The packaging also has distinct colored stripes and text for branding and regulatory compliance.*

FDA Label Image

Bildyos-60mg-pfs-blister-label (Bildyos 60mg Pfs Blister Label (2))

Label for BILDYOS (denosumab-nxxp) injection, 60 mg/mL, a sterile solution in a single-dose prefilled syringe with needle safety device. The label includes storage instructions to refrigerate at 2°C to 8°C and warnings not to freeze or shake excessively. The manufacturer is Shanghai Henlius Biotech, Inc., with Organon LLC as the labeler. The label also notes no preservatives and specifies subcutaneous use only.*

FDA Label Image

Bildyos-60mg-pfs-carton (Bildyos 60mg Pfs Carton (2))

Packaging label for BILDYOS (denosumab-nxxp) 60 mg/mL injection by Organon LLC. This single-dose prefilled syringe is for subcutaneous use only and contains no preservatives. The label includes dosing instructions, storage information, and a barcode. The design features the brand name, active ingredient, strength, and safety instructions.*

FDA Label Image

Bildyos-60mg-pfs-container-label (Bildyos 60mg Pfs Container Label (2))

Label for BILDYOS (denosumab-nxxp) injection, 60 mg/mL, for subcutaneous use only. The label includes NDC 78206-193-01 and indicates Rx only. Manufactured by Shanghai Henlius Biotech, Inc. for Organon LLC. The label also shows a barcode and mentions overlapping paste areas and a transparent area with some overprinting.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.